Cargando…

Hypoxia enhances anti-fibrotic properties of extracellular vesicles derived from hiPSCs via the miR302b-3p/TGFβ/SMAD2 axis

BACKGROUND: Cardiac fibrosis is one of the top killers among fibrotic diseases and continues to be a global unaddressed health problem. The lack of effective treatment combined with the considerable socioeconomic burden highlights the urgent need for innovative therapeutic options. Here, we evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Paw, Milena, Kusiak, Agnieszka A., Nit, Kinga, Litewka, Jacek J., Piejko, Marcin, Wnuk, Dawid, Sarna, Michał, Fic, Kinga, Stopa, Kinga B., Hammad, Ruba, Barczyk-Woznicka, Olga, Cathomen, Toni, Zuba-Surma, Ewa, Madeja, Zbigniew, Ferdek, Paweł E., Bobis-Wozowicz, Sylwia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617123/
https://www.ncbi.nlm.nih.gov/pubmed/37904135
http://dx.doi.org/10.1186/s12916-023-03117-w
_version_ 1785129537623818240
author Paw, Milena
Kusiak, Agnieszka A.
Nit, Kinga
Litewka, Jacek J.
Piejko, Marcin
Wnuk, Dawid
Sarna, Michał
Fic, Kinga
Stopa, Kinga B.
Hammad, Ruba
Barczyk-Woznicka, Olga
Cathomen, Toni
Zuba-Surma, Ewa
Madeja, Zbigniew
Ferdek, Paweł E.
Bobis-Wozowicz, Sylwia
author_facet Paw, Milena
Kusiak, Agnieszka A.
Nit, Kinga
Litewka, Jacek J.
Piejko, Marcin
Wnuk, Dawid
Sarna, Michał
Fic, Kinga
Stopa, Kinga B.
Hammad, Ruba
Barczyk-Woznicka, Olga
Cathomen, Toni
Zuba-Surma, Ewa
Madeja, Zbigniew
Ferdek, Paweł E.
Bobis-Wozowicz, Sylwia
author_sort Paw, Milena
collection PubMed
description BACKGROUND: Cardiac fibrosis is one of the top killers among fibrotic diseases and continues to be a global unaddressed health problem. The lack of effective treatment combined with the considerable socioeconomic burden highlights the urgent need for innovative therapeutic options. Here, we evaluated the anti-fibrotic properties of extracellular vesicles (EVs) derived from human induced pluripotent stem cells (hiPSCs) that were cultured under various oxygen concentrations. METHODS: EVs were isolated from three hiPSC lines cultured under normoxia (21% O(2); EV-N) or reduced oxygen concentration (hypoxia): 3% O(2) (EV-H3) or 5% O(2) (EV-H5). The anti-fibrotic activity of EVs was tested in an in vitro model of cardiac fibrosis, followed by a detailed investigation of the underlying molecular mechanisms. Sequencing of EV miRNAs combined with bioinformatics analysis was conducted and a selected miRNA was validated using a miRNA mimic and inhibitor. Finally, EVs were tested in a mouse model of angiotensin II-induced cardiac fibrosis. RESULTS: We provide evidence that an oxygen concentration of 5% enhances the anti-fibrotic effects of hiPS-EVs. These EVs were more effective in reducing pro-fibrotic markers in activated human cardiac fibroblasts, when compared to EV-N or EV-H3. We show that EV-H5 act through the canonical TGFβ/SMAD pathway, primarily via miR-302b-3p, which is the most abundant miRNA in EV-H5. Our results show that EV-H5 not only target transcripts of several profibrotic genes, including SMAD2 and TGFBR2, but also reduce the stiffness of activated fibroblasts. In a mouse model of heart fibrosis, EV-H5 outperformed EV-N in suppressing the inflammatory response in the host and by attenuating collagen deposition and reducing pro-fibrotic markers in cardiac tissue. CONCLUSIONS: In this work, we provide evidence of superior anti-fibrotic properties of EV-H5 over EV-N or EV-H3. Our study uncovers that fine regulation of oxygen concentration in the cellular environment may enhance the anti-fibrotic effects of hiPS-EVs, which has great potential to be applied for heart regeneration. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-023-03117-w.
format Online
Article
Text
id pubmed-10617123
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106171232023-11-01 Hypoxia enhances anti-fibrotic properties of extracellular vesicles derived from hiPSCs via the miR302b-3p/TGFβ/SMAD2 axis Paw, Milena Kusiak, Agnieszka A. Nit, Kinga Litewka, Jacek J. Piejko, Marcin Wnuk, Dawid Sarna, Michał Fic, Kinga Stopa, Kinga B. Hammad, Ruba Barczyk-Woznicka, Olga Cathomen, Toni Zuba-Surma, Ewa Madeja, Zbigniew Ferdek, Paweł E. Bobis-Wozowicz, Sylwia BMC Med Research Article BACKGROUND: Cardiac fibrosis is one of the top killers among fibrotic diseases and continues to be a global unaddressed health problem. The lack of effective treatment combined with the considerable socioeconomic burden highlights the urgent need for innovative therapeutic options. Here, we evaluated the anti-fibrotic properties of extracellular vesicles (EVs) derived from human induced pluripotent stem cells (hiPSCs) that were cultured under various oxygen concentrations. METHODS: EVs were isolated from three hiPSC lines cultured under normoxia (21% O(2); EV-N) or reduced oxygen concentration (hypoxia): 3% O(2) (EV-H3) or 5% O(2) (EV-H5). The anti-fibrotic activity of EVs was tested in an in vitro model of cardiac fibrosis, followed by a detailed investigation of the underlying molecular mechanisms. Sequencing of EV miRNAs combined with bioinformatics analysis was conducted and a selected miRNA was validated using a miRNA mimic and inhibitor. Finally, EVs were tested in a mouse model of angiotensin II-induced cardiac fibrosis. RESULTS: We provide evidence that an oxygen concentration of 5% enhances the anti-fibrotic effects of hiPS-EVs. These EVs were more effective in reducing pro-fibrotic markers in activated human cardiac fibroblasts, when compared to EV-N or EV-H3. We show that EV-H5 act through the canonical TGFβ/SMAD pathway, primarily via miR-302b-3p, which is the most abundant miRNA in EV-H5. Our results show that EV-H5 not only target transcripts of several profibrotic genes, including SMAD2 and TGFBR2, but also reduce the stiffness of activated fibroblasts. In a mouse model of heart fibrosis, EV-H5 outperformed EV-N in suppressing the inflammatory response in the host and by attenuating collagen deposition and reducing pro-fibrotic markers in cardiac tissue. CONCLUSIONS: In this work, we provide evidence of superior anti-fibrotic properties of EV-H5 over EV-N or EV-H3. Our study uncovers that fine regulation of oxygen concentration in the cellular environment may enhance the anti-fibrotic effects of hiPS-EVs, which has great potential to be applied for heart regeneration. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-023-03117-w. BioMed Central 2023-10-31 /pmc/articles/PMC10617123/ /pubmed/37904135 http://dx.doi.org/10.1186/s12916-023-03117-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Paw, Milena
Kusiak, Agnieszka A.
Nit, Kinga
Litewka, Jacek J.
Piejko, Marcin
Wnuk, Dawid
Sarna, Michał
Fic, Kinga
Stopa, Kinga B.
Hammad, Ruba
Barczyk-Woznicka, Olga
Cathomen, Toni
Zuba-Surma, Ewa
Madeja, Zbigniew
Ferdek, Paweł E.
Bobis-Wozowicz, Sylwia
Hypoxia enhances anti-fibrotic properties of extracellular vesicles derived from hiPSCs via the miR302b-3p/TGFβ/SMAD2 axis
title Hypoxia enhances anti-fibrotic properties of extracellular vesicles derived from hiPSCs via the miR302b-3p/TGFβ/SMAD2 axis
title_full Hypoxia enhances anti-fibrotic properties of extracellular vesicles derived from hiPSCs via the miR302b-3p/TGFβ/SMAD2 axis
title_fullStr Hypoxia enhances anti-fibrotic properties of extracellular vesicles derived from hiPSCs via the miR302b-3p/TGFβ/SMAD2 axis
title_full_unstemmed Hypoxia enhances anti-fibrotic properties of extracellular vesicles derived from hiPSCs via the miR302b-3p/TGFβ/SMAD2 axis
title_short Hypoxia enhances anti-fibrotic properties of extracellular vesicles derived from hiPSCs via the miR302b-3p/TGFβ/SMAD2 axis
title_sort hypoxia enhances anti-fibrotic properties of extracellular vesicles derived from hipscs via the mir302b-3p/tgfβ/smad2 axis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617123/
https://www.ncbi.nlm.nih.gov/pubmed/37904135
http://dx.doi.org/10.1186/s12916-023-03117-w
work_keys_str_mv AT pawmilena hypoxiaenhancesantifibroticpropertiesofextracellularvesiclesderivedfromhipscsviathemir302b3ptgfbsmad2axis
AT kusiakagnieszkaa hypoxiaenhancesantifibroticpropertiesofextracellularvesiclesderivedfromhipscsviathemir302b3ptgfbsmad2axis
AT nitkinga hypoxiaenhancesantifibroticpropertiesofextracellularvesiclesderivedfromhipscsviathemir302b3ptgfbsmad2axis
AT litewkajacekj hypoxiaenhancesantifibroticpropertiesofextracellularvesiclesderivedfromhipscsviathemir302b3ptgfbsmad2axis
AT piejkomarcin hypoxiaenhancesantifibroticpropertiesofextracellularvesiclesderivedfromhipscsviathemir302b3ptgfbsmad2axis
AT wnukdawid hypoxiaenhancesantifibroticpropertiesofextracellularvesiclesderivedfromhipscsviathemir302b3ptgfbsmad2axis
AT sarnamichał hypoxiaenhancesantifibroticpropertiesofextracellularvesiclesderivedfromhipscsviathemir302b3ptgfbsmad2axis
AT fickinga hypoxiaenhancesantifibroticpropertiesofextracellularvesiclesderivedfromhipscsviathemir302b3ptgfbsmad2axis
AT stopakingab hypoxiaenhancesantifibroticpropertiesofextracellularvesiclesderivedfromhipscsviathemir302b3ptgfbsmad2axis
AT hammadruba hypoxiaenhancesantifibroticpropertiesofextracellularvesiclesderivedfromhipscsviathemir302b3ptgfbsmad2axis
AT barczykwoznickaolga hypoxiaenhancesantifibroticpropertiesofextracellularvesiclesderivedfromhipscsviathemir302b3ptgfbsmad2axis
AT cathomentoni hypoxiaenhancesantifibroticpropertiesofextracellularvesiclesderivedfromhipscsviathemir302b3ptgfbsmad2axis
AT zubasurmaewa hypoxiaenhancesantifibroticpropertiesofextracellularvesiclesderivedfromhipscsviathemir302b3ptgfbsmad2axis
AT madejazbigniew hypoxiaenhancesantifibroticpropertiesofextracellularvesiclesderivedfromhipscsviathemir302b3ptgfbsmad2axis
AT ferdekpawełe hypoxiaenhancesantifibroticpropertiesofextracellularvesiclesderivedfromhipscsviathemir302b3ptgfbsmad2axis
AT bobiswozowiczsylwia hypoxiaenhancesantifibroticpropertiesofextracellularvesiclesderivedfromhipscsviathemir302b3ptgfbsmad2axis